Innovent Biologics, Inc. (HKG:1801)
Hong Kong · Delayed Price · Currency is HKD 87.70
+0.85 (0.98%)
Nov 5, 2025, 9:45 AM HKT
Innovent Biologics Market Cap
Innovent Biologics has a market cap or net worth of 148.82 billion as of November 4, 2025. Its market cap has increased by 96.94% in one year.
Market Cap
148.82B
Enterprise Value
142.07B
Revenue
12.52B
Ranking
n/a
PE Ratio
117.48
Stock Price
87.70
Market Cap Chart
Since October 31, 2018, Innovent Biologics's market cap has increased from 18.54B to 148.82B, an increase of 702.74%. That is a compound annual growth rate of 34.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 148.82B | 148.21% |
| Dec 31, 2024 | 59.96B | -13.32% |
| Dec 29, 2023 | 69.17B | 34.57% |
| Dec 30, 2022 | 51.40B | -27.14% |
| Dec 31, 2021 | 70.55B | -38.71% |
| Dec 31, 2020 | 115.10B | 243.36% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 31, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 265.66B |
| Hansoh Pharmaceutical Group Company | 217.09B |
| JD Health International | 198.49B |
| WuXi Biologics | 147.15B |
| Sino Biopharmaceutical | 127.28B |
| Akeso | 108.97B |
| Sichuan Kelun-Biotech Biopharmaceutical | 105.21B |
| Alibaba Health Information Technology | 94.27B |